OXALIPLATIN
- Product NDC
- 0955-1725
- 11-digit product format
- 009551725
- Labeler code
- 0955
- Product ID
- 0955-1725_dfd7b336-3bf2-43e1-8197-06d85be3fe11
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- oxaliplatin
- Dosage form
- INJECTION, SOLUTION, CONCENTRATE
- Route
- INTRAVENOUS
- Labeler
- Winthrop U.S.
- Application
- NDA021759
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start
- 2014-07-07
- Marketing end
- 0000-00-00
- Substance
- OXALIPLATIN
- Active strength
- 5 mg/mL
- Pharmacologic classes
- Platinum-based Drug [EPC],Platinum-containing Compounds [EXT]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0955-1725 | OXALIPLATIN INJECTION, SOLUTION, CONCENTRATE [WINTHROP U.S, A BUSINESS OF SANOFI-AVENTIS U.S. LLC] | 16 | Legacy NDC | 20231208_a98b4070-822f-4fba-a844-690ff5556f0b.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0955-1725-10 | 00955172510 | 1 VIAL, GLASS in 1 CARTON (0955-1725-10) > 10 mL in 1 VIAL, GLASS | 2014-07-07 | 0000-00-00 | No | No | Current |